Cargando…

Bioequivalent pharmacokinetics for generic and originator hepatitis C direct-acting antivirals

Mass production of low-cost, generic direct-acting antivirals (DAAs) will be required to achieve targets of eliminating hepatitis C (HCV) by 2030. The pharmaceutical companies Gilead and Bristol-Myers Squibb have granted voluntary licences (VLs) to generic companies to mass produce the DAAs sofosbuv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hill, Andrew, Tahat, Loai, Mohammed, Mohammed Khalil, Tayyem, Rabab Fayez, Khwairakpam, Giten, Nath, Sanjay, Freeman, James, Benbitour, Ismahane, Helmy, Sherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mediscript Ltd 2018
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892672/ https://www.ncbi.nlm.nih.gov/pubmed/29682307

Ejemplares similares

High sustained virological response rates using imported generic direct acting antiviral treatment for hepatitis C
por: Hill, Andrew, et al.
Publicado: (2017)

Price of a hepatitis C cure: Cost of production and current prices for direct-acting antivirals in 50 countries
por: Barber, Melissa J., et al.
Publicado: (2020)

Bioequivalence and Pharmacokinetic Profiles of Generic and Branded Obeticholic Acid in Healthy Chinese Subjects Under Fasting and Fed Conditions
por: Wang, Meng-Na, et al.
Publicado: (2021)

Generic-reference and generic-generic bioequivalence of forty-two, randomly-selected, on-market generic products of fourteen immediate-release oral drugs
por: Hammami, Muhammad M., et al.
Publicado: (2017)

Bioequivalence of generic and branded amoxicillin capsules in healthy human volunteers
por: Pathak, Priyanka, et al.
Publicado: (2017)

Pharmacokinetics and Bioequivalence Evaluation of Cyclobenzaprine Tablets
por: Brioschi, Tatiane Maria de Lima Souza, et al.
Publicado: (2013)

Sampling times and genotyping concerns in bioequivalence evaluation of branded and generic formulations
por: Zhao, Xiao-Ying, et al.
Publicado: (2013)

Physiologically‐based pharmacokinetic modeling to support bioequivalence and approval of generic products: A case for diclofenac sodium topical gel, 1%
por: Tsakalozou, Eleftheria, et al.
Publicado: (2021)

Evaluation of pharmacokinetics and safety with bioequivalence of Amlodipine in healthy Chinese volunteers: Bioequivalence Study Findings
por: Wang, Tongtong, et al.
Publicado: (2020)

Bioequivalence of Orally Administered Generic, Compounded, and Innovator‐Formulated Itraconazole in Healthy Dogs
por: Mawby, D.I., et al.
Publicado: (2013)

Effectiveness and safety of generic and brand direct acting antivirals for treatment of chronic hepatitis C
por: Abdulla, Maheeba, et al.
Publicado: (2022)

Swedish patients’ trust in the bioequivalence of interchangeable generics. What factors are important for low trust?
por: Olsson, Erika, et al.
Publicado: (2018)

Evaluating the bioequivalence of levetiracetam brand and generic oral tablets available in the Saudi market in vivo
por: ALRabeeah, Danah, et al.
Publicado: (2023)

Pilot study: bioequivalence of dihydroartemisinin in dihydroartemisinin-piperaquine tablet generic formulation in healthy Indonesian volunteers
por: Isnawati, Ani, et al.
Publicado: (2023)

A Multi-centric Bioequivalence Trial in Ph+ Chronic Myeloid Leukemia Patients to Assess Bioequivalence and Safety Evaluation of Generic Imatinib Mesylate 400 mg Tablets
por: Arora, Rachna, et al.
Publicado: (2016)

Evaluation of Pharmacokinetics and Safety with Bioequivalence of Ibuprofen Sustained-Release Capsules of Two Formulations, in Chinese Healthy Volunteers: Bioequivalence Study
por: Huang, Chunqi, et al.
Publicado: (2023)

Interchangeability of Generics—Experiences and Outlook Toward Pharmacokinetics Variability and Generic‐Generic Substitution
por: Yu, Yang, et al.
Publicado: (2018)

Pharmacokinetics and bioequivalence evaluation of lenalidomide in Chinese patients with multiple myeloma
por: Gao, Tiantao, et al.
Publicado: (2022)

Pharmacokinetics and bioequivalence of two cyclosporine oral solution formulations in cats
por: Yang, Yuxin, et al.
Publicado: (2022)

Correction: Viral Hepatitis as a Public Health Concern: A Narrative Review About the Current Scenario and the Way Forward
por: Bhadoria, Ajeet S, et al.
Publicado: (2022)

Viral Hepatitis as a Public Health Concern: A Narrative Review About the Current Scenario and the Way Forward
por: Bhadoria, Ajeet S, et al.
Publicado: (2022)

Quality of Reporting of Bioequivalence Trials Comparing Generic to Brand Name Drugs: A Methodological Systematic Review
por: van der Meersch, Amélie, et al.
Publicado: (2011)

Steady State Bioequivalence of Generic and Innovator Formulations of Stavudine, Lamivudine, and Nevirapine in HIV-Infected Ugandan Adults
por: Byakika-Tusiime, Jayne, et al.
Publicado: (2008)

Bioequivalence, Drugs with Narrow Therapeutic Index and the Phenomenon of Biocreep: A Critical Analysis of the System for Generic Substitution
por: Gozzo, Lucia, et al.
Publicado: (2022)

Pharmacokinetic Bioequivalence of Two Inhaled Tiotropium Bromide Formulations in Healthy Volunteers
por: Algorta, Jaime, et al.
Publicado: (2016)

Bioequivalence of the pharmacokinetics between tofacitinib aspartate and tofacitinib citrate in healthy subjects
por: Shin, Wonsuk, et al.
Publicado: (2020)

Pharmacokinetics and bioequivalence of two imidocarb formulations in cattle after subcutaneous injection
por: Wang, Honglei, et al.
Publicado: (2022)

Pharmacokinetic and Bioequivalence Study of Eldecalcitol Soft Capsules in Healthy Chinese Subjects
por: Li, Ting, et al.
Publicado: (2022)

Evaluation of model‐based bioequivalence approach for single sample pharmacokinetic studies
por: Tardivon, Coralie, et al.
Publicado: (2023)

Bioequivalence of Generic and Brand Name Clozapine in Korean Schizophrenic Patients: A Randomized, Two-Period, Crossover Study
por: Woo, Young Sup, et al.
Publicado: (2015)

Bioequivalence between innovator and generic tacrolimus in liver and kidney transplant recipients: A randomized, crossover clinical trial
por: Alloway, Rita R., et al.
Publicado: (2017)

Meeting Regulatory Requirements for Drugs with a Narrow Therapeutic Index: Bioequivalence Studies of Generic Once-Daily Tacrolimus
por: Gantar, Kaja, et al.
Publicado: (2020)

Bioequivalence and pharmacodynamics of a generic dabigatran etexilate capsule in healthy Chinese subjects under fasting and fed conditions
por: Li, Xin, et al.
Publicado: (2020)

Bioequivalence assessment of two formulations of ibuprofen
por: Al-Talla, Zeyad A, et al.
Publicado: (2011)

Open Flow Microperfusion as a Dermal Pharmacokinetic Approach to Evaluate Topical Bioequivalence
por: Bodenlenz, Manfred, et al.
Publicado: (2016)

Pharmacokinetic properties and bioequivalence of gefitinib 250 mg in healthy Korean male subjects
por: Moon, Seol Ju, et al.
Publicado: (2021)

Interchangeability of Generic Drugs: A Nonparametric Pharmacokinetic Model of Gabapentin Generic Drugs
por: Glerum, Pieter J., et al.
Publicado: (2018)

Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products of agomelatine in Chinese subjects
por: Tang, Fang, et al.
Publicado: (2016)

Immunosuppression with generic tacrolimus in liver and kidney transplantation—systematic review and meta‐analysis on biopsy‐proven acute rejection and bioequivalence
por: Kahn, Judith, et al.
Publicado: (2020)

Virtual population pharmacokinetic using physiologically based pharmacokinetic model for evaluating bioequivalence of oral lacidipine formulations in dogs
por: Yang, Bin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9096jt7vfe17qjsndf757ps9ki